firefly luciferin has been researched along with Cardiometabolic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheung, BMY; De Mey, JGR; Deng, HB; Elie, AGIM; Irmukhamedov, A; Jensen, PS; Luo, C; Man, AWC; Song, E; Vanhoutte, PM; Wang, Y; Xu, A; Yang, K; Yuen, KY; Zhang, J | 1 |
1 other study(ies) available for firefly luciferin and Cardiometabolic Syndrome
Article | Year |
---|---|
Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment.
Topics: Aged; Biomarkers; Body Mass Index; China; Female; Firefly Luciferin; Humans; Immunoassay; Incidence; Male; Metabolic Syndrome; Middle Aged; Naphthols; Prognosis; Risk Assessment | 2017 |